Amgen’s AMG510 combo exploration in colorectal cancer tumours poised for late 2019, early 2020
The theory behind combining AMG510 with a MEK inhibitor in CRC is that together they would target upstream and downstream KRAS events.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
-
ACTide by Nubilaria
Nubilaria Srl is an Information Technology (IT) company founded in...
About
Nubilaria Srl is an Information Technology (IT) company founded in 1999. Our company has its origins in the design, management and distribution of complex database systems and innovative IT services under strict international security policies.
FollowMake an Enquiry
-
Kognitic
Kognitic Clinical Trial Intelligence (CTI) is an automated and robust,...
About
Kognitic Clinical Trial Intelligence (CTI) is an automated and robust, insight-driven platform for life sciences, which accelerates our clients' drug development pipeline and investment decisions.
FollowMake an Enquiry
-
VaLea Clinical Trials
VaLea Clinical Trials specialises in providing convenient patient-centric services for...
About
VaLea Clinical Trials specialises in providing convenient patient-centric services for clinical trials in the home or alternate-site settings, based in Vienna, Austria.
FollowMake an Enquiry